In this study, the effect of combined PPARα activation and FGF15 overexpression on the efficacy of MASH treatment was determined in a high-fat diet (HFD)-induced MASH mouse model. This evidence concerns the gene PPARA and metabolic dysfunction-associated steatohepatitis.